Trump's New Drug Price Deal: Regeneron Aims for Affordability

Donald Trump is set to announce a new drug price deal with Regeneron. This comes as part of his ongoing efforts to make medications more affordable for Americans. The details of the agreement are still under wraps, but it aims to tackle high prescription costs that many people face today. What's interesting is that Regeneron is known for its innovative treatments, including its COVID-19 antibody therapy. This deal could potentially change how much patients pay out of pocket for these vital drugs. The bottom line is that this initiative could impact millions of Americans struggling with healthcare costs, making it a significant move in the ongoing conversation about drug pricing in the U.S.